Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Grifols (GRFS US)
Watchlist
Contact IR
30
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Grifols SA
•
02 Apr 2025 21:30
Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield
Brookfield's renewed interest in Grifols signals confidence in its turnaround, with strengthened financials and potential for improved future...
Jesus Rodriguez Aguilar
Follow
289 Views
Share
bearish
•
Svenska Handelsbanken AB
•
16 Mar 2025 22:45
Liquid Universe of European Ordinary and Preferred Shares: March '25 Report
European share-price spreads have generally tightened since mid-February, with volatility; Carlsberg B discount at 5-year record low,...
Jesus Rodriguez Aguilar
Follow
179 Views
Share
bullish
•
Telecom Italia SPA
•
16 Feb 2025 23:12
Liquid Universe of European Ordinary and Preferred Shares: February'25 Report
Since mid-January, share-price spreads have generally widened across European liquid universe of ordinary and preferred shares (11 have widened, 3...
Jesus Rodriguez Aguilar
Follow
244 Views
Share
bullish
•
CSL Ltd
•
12 Feb 2025 00:30
CSL Ltd (CSL AU): Weak Vaccine Sales Affect H1FY25 Performance; FY25 Guidance Maintained
CSL Ltd's H1FY25 net profit rises 6% YoY to $2.01B, missing estimates. Revenue is up 5% YoY to $8.48B. FY25 profit guidance reaffirmed at $3.2...
Tina Banerjee
Follow
362 Views
Share
bullish
•
Roche Holding
•
16 Jan 2025 13:18
Liquid Universe of European Ordinary and Preferred Shares: January'25 Report
Since mid-December, share-price spreads have generally tightened across European liquid universe of ordinary and preferred shares (8 have widened,...
Jesus Rodriguez Aguilar
Follow
310 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x